Incyte Corp.

INCY ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009 FY2008 FY2007 FY2006
Revenue $9.3M $46.9M $41.3M $13.7M
Jakafi Net Product Revenues $0 $0 $0
Other Net Product Revenues $0 $0 $0
Royalty Revenues $0 $0 $0
Milestone and Contract Revenues $46.9M $41.3M $13.7M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $119.4M
SG&A Expense $27.6M
Operating Income $-139.8M
Operating Margin -1,508.6%
Interest Expense $32.1M
Pretax Income
Income Tax Expense
Net Income $-211.9M
Net Margin -2,286.8%
EPS (Basic) $-2.06
EPS (Diluted) $-2.06
Shares Outstanding (Basic) 102.9M
Shares Outstanding (Diluted) 102.9M
Dividends Per Share
← Newer Page 3 of 3 Older →